Motherhood
Smart lactation pads can monitor safety of breast milk in real time

Scientists have developed a lactation pad equipped with sensing technology that allows parents of newborns to monitor breast milk in real time. The work shows that the device is capable of ensuring that breast milk contains safe levels of the painkiller acetaminophen, which is often prescribed after childbirth and can be transferred to breastfeeding infants.
To make the device, the researchers installed electrodes and tiny channels into a lactation pad – an apparatus that nursing parents often wear throughout the day to protect their clothes from leaking breast milk.
The smart lactation pad functions by measuring samples of the milk for acetaminophen as lactating parents go about their regular routines without requiring additional effort from the parent.
“Our device represents a major innovation,” said first author Maral Mousavi, an assistant professor of biomedical engineering at the University of Southern California (USC).
“It is the first wearable tool for direct biochemical analysis in breast milk and the first lactation pad embedded with real-time sensing technology. This technology has the potential to empower lactating individuals with actionable health insights, supporting both maternal and infant health in ways that have never before been possible.”
Since the smart pad continuously monitors levels of acetaminophen in the milk throughout the day, it also offers a tool for scientists to better understand how drugs are transferred into breast milk, says Mousavi.
“While it is generally safe at recommended doses, acetaminophen overexposure is a leading cause of acute liver failure in children,” she said.
“It remains the most common reason for liver transplants related to drug toxicity.”
The researchers were inspired to build the lactation pad after a graduate student in their research group gave birth and was prescribed acetaminophen to manage her postpartum pain.
Despite the importance of breast milk as a source of nutrition for infants and its ability to help their fragile immune systems develop, the team found that few technologies existed to monitor its safety in real time. While a few companies offer mail-in services, these services involve collecting samples in specialised kits that can be costly and waiting days or weeks for results.
“Given the risks and the critical decision-making parents face around breastfeeding and medication use, we wanted to create a tool that empowers them with real-time, personalised information rather than leaving them to rely on generalized drug-safety charts or delayed lab testing,” said Mousavi.
The team hopes that the smart lactation pad can help parents make more informed decisions about breastfeeding after taking medications, such as optimising the “pump and dump” strategy or discarding breast milk when drug levels are the highest.
In addition to painkillers, the authors note that new mothers are also commonly prescribed antibiotics or anti-fungals, and although these medications are generally considered safe to take while breastfeeding, they aren’t always benign.
While the version of the smart pad described in this study was developed to measure acetaminophen, Mousavi says that it can be adapted to detect other drugs and biomarkers for assessing health.
For example, Mousavi and colleagues recently demonstrated another lactation pad with an embedded sensor designed to monitor glucose levels in breast milk—a function which she says could help parents manage their nutrition and address conditions such as gestational diabetes.
Currently, the device is only able to measure milk produced from natural leakage, meaning its applications may be limited when little leakage occurs. The pads are also disposable, so a new lactation pad is required for each new test. The researchers are currently working to develop a version of the device that analyses pumped milk to offer a more accessible and convenient testing option for parents.
Pregnancy
Women’s health strategy a ‘missed opportunity,’ RCM says
Pregnancy
Scotland to publish dedicated miscarriage patient charter

Scotland is set to publish the UK’s first dedicated miscarriage patient charter, giving women and families clear information on NHS care and support.
Commissioned by the Scottish Government and developed with baby-loss charities Tommy’s, Held In Our Hearts and the Miscarriage Association, the charter sets out minimum standards for compassionate, clinically appropriate and culturally competent miscarriage care across Scotland.
It builds on the Scottish Government’s Delivery Framework for Miscarriage Care, which has already changed practice across NHS boards.
Jenni Minto, Scottish public health and women’s health minister, said: “Miscarriage is devastating, and for too long women have not had the care and support they deserve.
“That is changing. Scotland will become the first country in the UK to publish a miscarriage patient charter, meaning women know exactly how they will be supported by health services following their loss.”
Unlike previous UK-wide norms, where women were typically offered enhanced support only after three miscarriages, Scotland’s approach means women can receive appropriate support after their first miscarriage.
The charter also sets out clear rights and expectations so every woman, regardless of location or circumstance, understands the care she should receive.
It includes access to private rooms in hospitals rather than busy clinical areas or maternity settings, progesterone treatment where clinically appropriate, compassionate and culturally competent bereavement support, and clear information in 18 languages, including British Sign Language and audio formats.
Progesterone is a hormone that growing evidence suggests may help reduce the risk of miscarriage in certain cases when given to women who meet specific clinical criteria.
The Scottish Government said the charter is designed to ensure personalised, respectful care and to address long-standing inequalities experienced by women during miscarriage.
It is intended to provide clarity on the support women can expect, consistent standards across all NHS boards, stronger awareness and confidence among healthcare professionals, and better access to emotional and practical support services.
Charities involved in its development said many women still report feeling dismissed, uninformed or unsupported during miscarriage.
They said the new charter marks an important step towards making sure every woman feels heard, respected and cared for.
The charter aligns with Scotland’s wider Women’s Health Plan, which is improving care across reproductive, menstrual, maternal and perinatal health.
Recent national developments include greater investment in women’s health services, improved training for healthcare staff, new digital and in-person support tools, and targeted action to reduce inequalities in access and outcomes.
Together, these measures aim to create a more compassionate and equitable women’s health system.
Minto said: “This charter is a landmark moment.
“It tells women clearly what they should expect from their NHS, and it holds services to account for delivering it.
“Scotland is leading the way, and I am proud of the progress NHS boards and our charity partners have made together.”
The model is expected to inform wider UK discussions on miscarriage support, bereavement care and early pregnancy services.
The charter will be made publicly available, offering women, partners and families clear guidance on their rights and the standards they can expect when seeking care.
Motherhood
The maternity care crisis hiding in plain sight

By Adrianne Nickerson, founder and CEO, Oula
The numbers get the headlines. Maternal mortality rates. Access deserts. Workforce shortages. These are real and urgent problems, but they’re not the whole story.
There’s a quieter breakdown happening inside routine appointments, and it’s driving outcomes in ways that never show up in formal reports.
Women describe maternity care that feels rushed and transactional.
They talk about repeating their medical history at every visit, leaving appointments with questions they never got to ask, and receiving advice so generic it doesn’t seem to account for their actual lives.
These aren’t just complaints about bedside manner. They’re signals that the system is losing the thread, and when that happens, clinical risk follows.
A patient who doesn’t feel heard may decide a new symptom isn’t worth mentioning.
A patient who leaves an appointment without clear next steps may wait too long to call when something changes. These small moments of disconnection are where complications quietly take shape.
The system is structured to rush
This isn’t about individual clinicians failing women. It’s about a care model built around short, physician-led visits with limited coordination across roles — applied to pregnancies that are often medically and emotionally complex.
Clinicians are covering more ground in less time, and patients feel that compression. Women in marginalised communities feel it most acutely.
Reports of dismissal and bias are well-documented, and the consequences compound: when trust erodes, communication breaks down, and the window for early intervention narrows.
What women are actually asking for
Younger women in particular are entering maternity care with different expectations. They want explanations for recommendations, not just instructions.
They want to understand tradeoffs and have their preferences carry forward from one visit to the next. They’re not looking to reduce medical oversight, they’re looking for care that makes sense as a whole.
That’s driving real interest in collaborative care models that bring OBs, midwives, nurses, and behavioural health professionals into a coordinated framework.
When roles are clear and communication is shared rather than siloed, the experience changes, and so do outcomes.
Experience is clinical performance
Health systems are sophisticated at tracking infection rates and readmissions. The experience of care deserves the same level of attention, because it’s often where the clinical picture first starts to slip.
The fixes aren’t mysterious. A longer first visit can prevent confusion that compounds over months. Integrated mental health support surfaces concerns that might otherwise go unspoken.
Clear communication across the care team eliminates the mixed messages that erode confidence.
Postpartum services like pelvic floor therapy and lactation support – when easy to access and clearly explained – extend the impact of care well beyond delivery.
Workforce shortages and financial pressure make all of this harder. They also make it more urgent.
When women feel respected and informed, they raise concerns earlier, follow care plans more consistently, and seek help sooner.
That’s not a soft outcome – that’s how complications get prevented.
Simply put: adjusting how care is delivered is one of the most direct ways to improve clinical outcomes.
Entrepreneur2 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Menopause4 weeks agoCalifornia plans US$3.4m menopause care overhaul
Hormonal health3 weeks agoWatchdog bans five ads for women’s heath claims
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Entrepreneur3 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
News2 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Opinion3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up















